Betahistine-KV tablets 8 mg No. 30
Betahistine-KV tablets are prescribed for the following indications:
Meniere's disease and syndrome, which are characterized by three main symptoms: dizziness, sometimes accompanied by nausea and vomiting; hearing loss (deafness); tinnitus. Symptomatic treatment of vestibular vertigo of various origins.Composition
Active ingredient: betahistine dihydrochloride;
1 tablet contains betahistine dihydrochloride in terms of 100% substance 8 or 16 or 24 mg;
Excipients: microcrystalline cellulose, mannitol (E 421), colloidal anhydrous silicon dioxide, talc, citric acid monohydrate, stearic acid.
Contraindication
Hypersensitivity to any of the components of the drug. Pheochromocytoma.
Method of application
The daily dose for adults is 24-48 mg, evenly distributed throughout the day.
The dose should be selected individually, depending on the effect. A decrease in symptoms is sometimes observed only after two to three weeks of treatment. The best results are sometimes achieved when taking the drug for several months. There is evidence that prescribing treatment early in the disease prevents its progression and / or hearing loss in the later stages.
Application features
Pregnant women
Betahistine should not be used during pregnancy unless clearly necessary.
Children
Due to insufficient data on safety and efficacy, this medicine is not recommended for use in children (under 18 years of age).
Drivers
Betahistine is indicated for the treatment of Ménière's syndrome, which is characterized by a triad of core symptoms: dizziness, hearing loss, tinnitus, - and for the symptomatic treatment of vestibular vertigo. Both conditions may adversely affect the ability to drive and use machines. Betahistine is known to have no or negligible influence on the ability to drive and use machines.
Overdose
Several cases of drug overdose are known. Some patients experienced mild to moderate symptoms (nausea, drowsiness, abdominal pain) after taking the drug in doses up to 640 mg. More serious complications (convulsions, cardiopulmonary complications) were observed with intentional administration of increased doses of betahistine, especially in combination with overdose of other drugs.
Treatment of overdose should include standard supportive measures.
Side effects
Gastrointestinal: nausea and dyspepsia, minor stomach upset (vomiting, gastrointestinal pain, bloating and flatulence). These side effects usually disappear when the drug is taken with food or after reducing the dose. Nervous system: headache. Immune system: hypersensitivity reactions, such as anaphylaxis. Skin and subcutaneous tissue: hypersensitivity reactions of the skin and subcutaneous tissue, including angioedema, rash, itching and urticaria, have been observed.Interaction
Since betahistine is a histamine analogue, the interaction of betahistine with antihistamines could theoretically affect the effectiveness of one of these drugs.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Shelf life - 3 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.